Purushotham Naidu

Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients (Pts) with Very High/High-Risk Myelodysplastic Syndrome (vHR/HR-MDS) and Acute Myeloid Leukemia (AML): Final Analysis from a Phase Ib Study

Andrew M. Brunner, Jordi Esteve, Kimmo Porkka et al. · Blood · 2021 · 101 citations

Medicine, Hematology, Oncology +17

Efficacy and Safety of Sabatolimab (MBG453) in Combination with Hypomethylating Agents (HMAs) in Patients with Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (HR-MDS): Updated Results from a Phase 1b Study

Andrew M. Brunner, Jordi Esteve, Kimmo Porkka et al. · Blood · 2020 · 70 citations

Medicine, Oncology, Pharmacology +16

AML-190: Anti-TIM-3 Antibody MBG453 in Combination with Hypomethylating Agents (HMAs) in Patients with High-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia: A Phase 1 Study

Andrew M. Brunner, Uma Borate, Jordi Esteve et al. · Clinical Lymphoma Myeloma & Leukemia · 2020 · 18 citations

Medicine, Hematology, Oncology +17

HMG-CoA reductase is not the site of the primary defect in phytosterolemia

G M Berger, R.J. Pegoraro, Shailendra B. Patel et al. · Journal of Lipid Research · 1998 · 13 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

Diffusion tensor imaging in evaluation of posterior fossa tumors in children on a 3T MRI scanner

Zarina Assis, Jitender Saini, Manish Ranjan et al. · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · 2015 · 11 citations · Full text

Medicine, Neurology, Radiology +17